title: The effect of cocoa supplementation on hepatic steatosis, reactive oxygen species and LFABP in a rat model of NASH.
abstract: BACKGROUND
  Non alcoholic steatohepatitis is hypothesised to develop via a mechanism involving fat accumulation and oxidative stress. The current study aimed to investigate if an increase in oxidative stress was associated with changes in the expression of liver fatty acid binding protein in a rat model of non alcoholic steatohepatitis and whether cocoa supplementation attenuated those changes.
  
  
  METHODS
  Female Sprague Dawley rats were fed a high fat control diet, a high fat methionine choline deficient diet, or one of four 12.5% cocoa supplementation regimes in combination with the high fat methionine choline deficient diet.
  
  
  RESULTS
  Liver fatty acid binding protein mRNA and protein levels were reduced in the liver of animals with fatty liver disease when compared to controls. Increased hepatic fat content was accompanied by higher levels of oxidative stress in animals with fatty liver disease when compared to controls. An inverse association was found between the levels of hepatic liver fatty acid binding protein and the level of hepatic oxidative stress in fatty liver disease. Elevated NADPH oxidase protein levels were detected in the liver of animals with increased severity in inflammation and fibrosis. Cocoa supplementation was associated with partial attenuation of these pathological changes, although the severity of liver disease induced by the methionine choline deficient diet prevented complete reversal of any disease associated changes. Red blood cell glutathione was increased by cocoa supplementation, whereas liver glutathione was reduced by cocoa compared to methionine choline deficient diet fed animals.
  
  
  CONCLUSIONS
  These findings suggest a potential role for liver fatty acid binding protein and NADPH oxidase in the development of non alcoholic steatohepatitis. Furthermore, cocoa supplementation may have be of therapeutic benefit in less sever forms of NASH.
authors.affiliation: School of Medicine, Deakin University, Waurn Ponds, Australia. paul.lewandowski@deakin.edu.au.
authors.forename: Mile
authors.initials: M
authors.lastname: Janevski
authors.forename: Kiriakos N
authors.initials: KN
authors.lastname: Antonas
authors.forename: Melanie J
authors.initials: MJ
authors.lastname: Sullivan-Gunn
authors.forename: Maree A
authors.initials: MA
authors.lastname: McGlynn
authors.forename: Paul A
authors.initials: PA
authors.lastname: Lewandowski
references.citation: Biochem Biophys Res Commun. 2008 Jul 4;371(3):441-5
references.pmid: 18452708
references.citation: World J Gastroenterol. 2008 Jan 14;14(2):185-92
references.pmid: 18186553
references.citation: Arch Biochem Biophys. 2002 Oct 1;406(1):40-6
references.pmid: 12234488
references.citation: Hepatology. 2005 Jun;41(6):1313-21
references.pmid: 15915461
references.citation: J Clin Invest. 2000 Oct;106(7):867-72
references.pmid: 11018074
references.citation: Hepatology. 2007 Jun;45(6):1366-74
references.pmid: 17476695
references.citation: J Hepatol. 2008;48 Suppl 1:S104-12
references.pmid: 18304679
references.citation: Dig Liver Dis. 2009 Sep;41(9):615-25
references.pmid: 19223251
references.citation: Nutrition. 2005 May;21(5):594-601
references.pmid: 15850966
references.citation: J Gastroenterol Hepatol. 2007 Jun;22(6):778-87
references.pmid: 17565630
references.citation: J Hepatol. 2003 Nov;39(5):756-64
references.pmid: 14568258
references.citation: Am J Physiol Gastrointest Liver Physiol. 2009 Dec;297(6):G1053-65
references.pmid: 19815623
references.citation: Liver Int. 2005 Feb;25(1):33-40
references.pmid: 15698396
references.citation: Ann N Y Acad Sci. 1997 Sep 20;827:536-40
references.pmid: 9329786
references.citation: Biochem J. 2007 Aug 15;406(1):105-14
references.pmid: 17501721
references.citation: Anal Biochem. 2000 Oct 15;285(2):194-204
references.pmid: 11017702
references.citation: J Hepatol. 2007 Feb;46(2):304-13
references.pmid: 17157947
references.citation: Biochem Biophys Res Commun. 2000 Oct 5;276(3):945-51
references.pmid: 11027573
references.citation: J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S377-84
references.pmid: 12472967
references.citation: Mol Cell Biochem. 2007 Jan;295(1-2):27-34
references.pmid: 16924418
references.citation: Scand J Gastroenterol. 2009;44(9):1121-31
references.pmid: 19606393
references.citation: Clin Chim Acta. 2003 Jul 1;333(1):19-39
references.pmid: 12809732
references.citation: Hypertension. 2005 Aug;46(2):398-405
references.pmid: 16027246
references.citation: Am J Physiol Gastrointest Liver Physiol. 2001 May;280(5):G1005-12
references.pmid: 11292610
references.citation: J Clin Invest. 2005 Feb;115(2):209-18
references.pmid: 15690074
references.citation: Hepatol Int. 2008 Sep;2(3):316-21
references.pmid: 19669260
references.citation: J Lipid Res. 2009 Dec;50(12):2445-54
references.pmid: 19474456
references.citation: Mol Cell Biochem. 2009 Apr;324(1-2):101-15
references.pmid: 19104910
references.citation: Obes Rev. 2010 Jun;11(6):430-45
references.pmid: 19845871